Jubilant Pharmova's US Subsidiary Strengthens Financial Position with $25 Million Term Loan Prepayment

Unknown Apr 02, 2026 800 Views

Jubilant Pharmova Limited announced that its wholly-owned subsidiary, Jubilant Pharma Holdings Inc. (JPHI), has voluntarily prepaid $25 million of its term loan in January 2025. This prepayment is part of the company’s ongoing efforts to optimize its debt profile and reduce interest expense...

Stay Ahead – Explore Now! SEBI Board to Consider Open Market Buyback Revival and Pricing Norms